Lumasiran (sodium), CAS [[1834612-06-4]]

Produktübersicht

• Artikelname: Lumasiran (sodium), CAS [[1834612-06-4]]
• Artikelnummer: MCE-HY-132613
• Hersteller Artikelnummer: HY-132613
• Alternativnummer: MCE-HY-132613-10MG,MCE-HY-132613-50MG,MCE-HY-132613-1MG,MCE-HY-132613-100MG,MCE-HY-132613-25MG,MCE-HY-132613-5MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

Lumasiran sodium, an investigational RNA interference (RNAi) therapeutic agent, reduces hepatic oxalate production by targeting glycolate oxidase. Lumasiran sodium reduces urinary oxalate excretion, the cause of progressive kidney failure in primary hyperoxaluria type 1 (PH1) [1][2].

Produkteigenschaften

• Molekulargewicht: 16339.00
• Reinheit: 99.21
• CAS Nummer: [1834612-06-4]
• Formel: C530H668F10N173Na44O320P43S6
• Target-Kategorie: Glycolate Oxidase,Small Interfering RNA (siRNA)

Anwendungsbeschreibung

• Anwendungsbeschreibung: Oligonucleotides